|
Read the latest links to relevant and valuable industry articles.
|
For convenient access to MLMIC articles, industry news and risk management resources, please visit the new MLMIC Insider.
|
In collaboration with groups and organizations across the state, MLMIC offers Preferred Savings Programs for qualifying New York Physicians. Learn More.
|
|
|
|
|
Nasal Spray Alternative to EpiPen Faces Setback as FDA Seeks Fresh Study
|
reuters.com - The U.S. health regulator has declined to approve a nasal spray that would have been the first needle-free emergency treatment for allergic reactions, a surprise decision that pushed shares of its developer ARS Pharmaceuticals to a record low.
|
|
|
|
Powerful Animal Tranquilizer Xylazine Present in Drug Tests Across the US, Analysis Finds
|
fiercehealthcare.com - Xylazine, a powerful veterinary tranquilizer, was detected in drug tests in 34 states from every region of the country, according to a new analysis.
|
|
|
|
Synthetic Thyroid Hormone May Lower Cholesterol, Treat Obesity
|
medicalnewstoday.com - A thyroid hormone-mimicking drug delivered straight to the liver may reduce cholesterol levels and reverse obesity.
|
|
|
|
How Healthcare Education Must Evolve: 3 Clinicians Weigh In
|
beckershospitalreview.com - Actively practicing physicians and nurses shared with Becker's what they wish they had learned in medical school and how they believe healthcare and medical education should evolve in the future.
|
|
|
|
Admissions, Symptoms and Origins: 6 COVID-19 Updates
|
beckershospitalreview.com - COVID-19 hospital admissions and deaths have risen for the eighth consecutive week, according to the CDC's most recent data tracking these metrics through Sept. 2.
|
|
|
|
|
|
With 45+ years of New York-specific experience, MLMIC is New York’s #1 medical liability insurer – providing physicians, dentists, hospitals and groups with expert insight and concierge-level service backed by the power and resources of a Berkshire Hathaway company. For the latest Best's rating, access AMBest.com.
|
|
|
|
|
|